Avation Medical Receives Tech Recognition

Columbus Business First honors the company’s Vivally® System as advanced BizTech innovation.

Columbus, Ohio (July 31, 2024) – Avation Medical, an innovative neuromodulation and digital health company on a mission to make non-invasive, physiologic, closed-loop neuromodulation accessible to patients across a variety of clinical conditions, has been recognized by Columbus Business First weekly news organization as a 2024 BizTech award honoree. The BizTech awards recognize the most promising startups, entrepreneurs, and innovators reshaping the ecosystem in the Columbus region.

“Columbus has been an ideal ecosystem of innovation and entrepreneurship for our business,” said Jill Schiaparelli, Avation Medical Co-founder and CEO. “Recognitions like this continue to fuel our mission of improving the lives of the more than 500 million people globally who suffer from the life-altering chronic conditions of overactive bladder (OAB) and urinary incontinence. OAB significantly interrupts everyday activities like traveling, working, socializing, and being active, and can lead to isolation and depression. Our purpose is to change this.”

Avation Medical created the only patient-centered solution to chronic bladder conditions, the Vivally® System, the first physiologic closed-loop, non-invasive neuromodulation therapy with a digital support application. Worn on the ankle, Vivally is used by patients at home for therapy sessions lasting only 30 minutes as little as once per week. Because Vivally requires no surgery, drugs, or needles, it sets a new standard for the treatment of OAB. Vivally is available in select geographies in the United States.

About Avation Medical and the Vivally System

Avation Medical is an innovative neuromodulation and digital health company with a mission to make non-invasive, physiologic closed-loop neuromodulation accessible to patients across a variety of clinical conditions. The company’s Vivally System is the only FDA-cleared, physiologic closed-loop, at-home wearable neuromodulation device system to treat symptoms of OAB. Combined with a companion mobile application, Vivally offers a comprehensive therapy and support system for patients suffering from urge urinary incontinence and urinary urgency caused by overactive bladder syndrome (OAB). Vivally is prescribed by a clinician following a brief clinical calibration which establishes an EMG target and range of neuromodulation energy needed for consistent nerve activation. Vivally delivers clinically effective therapy in as little as one 30-minute session once per week. Vivally is available by prescription in select geographies in the United States. Learn more at Avation.com.